Cardiorenal Effects of Newer NSAIDs (Celecoxib) versus Classic NSAIDs (Ibuprofen) in Patients with Arthritis
2011

Cardiorenal Effects of Celecoxib vs Ibuprofen in Arthritis Patients

Sample size: 792 publication 10 minutes Evidence: high

Author Information

Author(s): Hegazy Ragia, Alashhab Mohamed, Amin Madiha

Primary Institution: Benha Faculty of Medicine, Benha University

Hypothesis

Celecoxib has reduced cardiorenal toxicity compared to ibuprofen in patients with arthritis.

Conclusion

Celecoxib is associated with a lower incidence of cardiorenal toxicity compared to ibuprofen.

Supporting Evidence

  • Patients taking celecoxib had significantly lower rates of hypertension compared to those taking ibuprofen.
  • Serum creatinine levels increased significantly in patients treated with ibuprofen compared to celecoxib.
  • Creatinine clearance was significantly lower in patients treated with ibuprofen compared to those treated with celecoxib.

Takeaway

This study found that celecoxib is safer for the heart and kidneys than ibuprofen for people with arthritis.

Methodology

The study involved 792 arthritic patients who were treated with either celecoxib or ibuprofen for 6 months, with various health effects monitored.

Potential Biases

Potential bias due to the exclusion of patients with renal insufficiency.

Limitations

The study did not include patients with abnormal renal functions at baseline, which may limit the applicability of the results.

Participant Demographics

Mean age was about 55 years, with 69%-71% being female.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2011/862153

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication